Skip to content

Comparison of Calcium Sulphate Hemihydrate And Calciun Sulphate Hemihydrate - PRF in Chronic Periodontitis Patients.

Comparative Clinical and Radiographic Evaluation of the Effect of Nanocrystalline Calcium Sulphate Alloplast (NanogenTM) and Calcium Sulphate Hemihydrate- Platelet Rich Fibrin (CSH-PRF) as Graft in the Treatment of Intrabony Defects in Chronic Periodontitis Patients- A Randomised Clinical Trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/019260
Enrollment
40
Registered
2019-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Calcium Sulphate Hemihydrate with PRF: Calcium Sulphate Hemihydtate along with PRF act as scaffolding for osteoblast therby helps in bone regeneration.Calcium sulphate itself is ostecon

Sponsors

DrPayal Ramteke
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age group between 20-60years Diagnosis with chronic periodontitis Patients in good systemic health with no contraindication to periodontal surgery Patients having Intrabony defects with pocket depths of >= 5mm,intrabony defect of >= 3mm with radiographic evidence of vertical / angular bone loss in the affected sites. Involved teeth to be vital and with no endodontic lesion.

Exclusion criteria

Exclusion criteria: One â?? wall osseous defects. Patients suffering from any systemic diseases or with compromised immune system. Patients who had received any type of periodontal therapy for the past 6 months Patients taking any immuno-suppressive drugs like corticosteroids Patients with a known history of allergy to doxycycline or Chlorhexidine or any other medicine are used in the study. Patients showing unacceptable oral hygiene compliance during / after the phase I therapy. Patients taking any drug known to cause gingival enlargement. Pregnant and/or lactating mothers. Patients who were smokers or had tobacco in any other form. Endodontically treated teeth. Patient on anticoagulant therapy Patient with bleeding disorders.

Design outcomes

Primary

MeasureTime frame
Plaque Index (P.I.) (SILNESS & LOE, 1964). Gingival Index (G.I.) (LOE &SILNESS, 1963). 3Probing Pocket Depth (PPD). Clinical Attachment Level (CAL). Timepoint: Indices 1 month 3 months 6onths Probing 3 months 6 Months

Secondary

MeasureTime frame
Radiographic bone fill will be evaluated using intraoral periapical radiographs of the surgical site.Timepoint: Radiographs will be taken immediatly post surgery and at six month post surgery

Countries

India

Contacts

Public ContactPayal Pitambar Ramteke

NAIR HOSPITAL DENTAL COLLEGE MUMBAI

maladixit25@gmail.com9223340938

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026